NASDAQ · ASTH
Astrana Health, Inc.
Healthcare · Medical - Care Facilities
$35.57▲ 0.34% ($0.12)at close
As of 4:00 PM ET
Market cap
$1.76B
P/E
Valuation
Revenue & margin DCF
Verdict: fairly priced. Price between Bear and Base.
The price needs 12.3% revenue growth a year for 10 years. Our scenarios assume 14.1–24.4%.
That's below its past 4-year pace of 42.4%.
Value per share
Base case
$70.01
Price used $35.57 is 49% below this
USD · TTM ending Jun 30, 2026 · Price Sep 30, 8:00 PM UTC
Revenue each value needs
Revenue today $3.8B. The price needs $12.3B by 2036. Base case: $23B. At its recent pace: $132B. Bear to Bull: $14.3B to $34.2B.
Revenue today $3.8B. The price needs $12.3B by 2036. Base case: $23B. At its recent pace: $132B. Bear to Bull: $14.3B to $34.2B.
Revenue in 2036
today $3.8B
−$10.8Bless than the Base case
Value per share · Base case
$70.01
Price $35.57
49% below this
- 10-yr revenue CAGR
- 19.6%
- Ending operating margin
- 2.6%
- Discount rate
- 8.4%
USD · TTM ending Jun 30, 2026 · Price Sep 30, 8:00 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock rose 25.47% over the last year. Revenue grew 58.91% over the trailing twelve months. Operating margin moved from 2.9% to 2.61%. Free cash flow grew 30.68% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 9th percentile of their historical P/FCF range.
What would invalidate this read
Operating margin is at 2.61%. Revenue grew 58.91% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Return analysis
Company profile
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985.
Market multiples
Stock splits
Every 10 shares became 1
Every 136 shares became 1
Every 136 shares became 1
Profitability & growth
Analyst consensus
10
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 5, 2026
Q3 FY26 · EPS est $0.44 · Revenue est $1.02B
View
Institutional Sentiment
Astrana Health, Inc. · ASTH
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.